ClinicalTrials.gov record
Completed Phase 2 Interventional

Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill

ClinicalTrials.gov ID: NCT06597058

Public ClinicalTrials.gov record NCT06597058. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill Administered to Subjects With Alzheimer's Disease

Study identification

NCT ID
NCT06597058
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Noah Pharmaceuticals, Inc.
Industry
Enrollment
121 participants

Conditions and interventions

Interventions

  • MAR Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 15, 2024
Primary completion
Nov 4, 2025
Completion
Dec 14, 2025
Last update posted
Apr 7, 2026

2024 – 2025

United States locations

U.S. sites
16
U.S. states
8
U.S. cities
14
Facility City State ZIP Site status
Scottsdale Clinical Trials (Noah Clinical Site 017) Scottsdale Arizona 85260
Marvel Clinical Research (Noah Clinical Site 010) Huntington Beach California 92647
Accel Research Sites (Noah Clinical Site 019) DeLand Florida 32720
Health Awareness (Noah Clinical Site 020) Jupiter Florida 33458
Life Well Research Center (Noah Clinical Site 008) Miami Florida 33134
Regenerate Primary Medical Research (Noah Clinical Site 003) Miami Florida 33134
Miami Jewish Health (Noah Clinical Site 023) Miami Florida 33137
Neurology Associates of Ormond Beach (Noah Clinical Site 015) Ormond Beach Florida 32174
International Medical Investigational Centers (Noah Clinical Site 001) Palmetto Bay Florida 33176
Best Choice Medical and Research Service (Noah Clinical Site 025) Pembroke Pines Florida 33024
Denali Health Plant City, LLC (Noah Clinical Site 024) Plant City Florida 33563
Boston Clinical Trials (Noah Clinical Site 006) Boston Massachusetts 02131
IMA Clinical Research (Noah Clinical Site 004) Albuquerque New Mexico 87109
Carolina Research Center, Inc. (Noah Clinical Site 009) Shelby North Carolina 28150
Tekton Research (Noah Clinical Site 002) Yukon Oklahoma 73099
Olympus Clinical Research (Noah Clinical Site 014) Katy Texas 77450

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06597058, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06597058 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →